Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$91.25
-3.6%
$86.17
$33.35
$97.59
$2.78B1.07444,277 shs912,721 shs
Glaukos Corporation stock logo
GKOS
Glaukos
$170.60
+0.0%
$141.42
$73.16
$184.00
$10.06B0.78897,596 shs705,741 shs
Globus Medical, Inc. stock logo
GMED
Globus Medical
$80.64
-1.1%
$79.35
$52.68
$101.40
$11.06B0.951.59 million shs1.39 million shs
Teleflex Incorporated stock logo
TFX
Teleflex
$137.18
-2.1%
$131.41
$100.18
$144.19
$6.20B0.81463,392 shs645,242 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-3.55%-0.74%-0.34%+26.68%+107.25%
Glaukos Corporation stock logo
GKOS
Glaukos
+0.24%+5.33%+14.76%+26.99%+93.51%
Globus Medical, Inc. stock logo
GMED
Globus Medical
-1.05%-0.83%+0.21%-5.19%+50.51%
Teleflex Incorporated stock logo
TFX
Teleflex
-2.06%+2.00%+2.10%+4.01%+19.37%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$91.25
-3.6%
$86.17
$33.35
$97.59
$2.78B1.07444,277 shs912,721 shs
Glaukos Corporation stock logo
GKOS
Glaukos
$170.60
+0.0%
$141.42
$73.16
$184.00
$10.06B0.78897,596 shs705,741 shs
Globus Medical, Inc. stock logo
GMED
Globus Medical
$80.64
-1.1%
$79.35
$52.68
$101.40
$11.06B0.951.59 million shs1.39 million shs
Teleflex Incorporated stock logo
TFX
Teleflex
$137.18
-2.1%
$131.41
$100.18
$144.19
$6.20B0.81463,392 shs645,242 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-3.55%-0.74%-0.34%+26.68%+107.25%
Glaukos Corporation stock logo
GKOS
Glaukos
+0.24%+5.33%+14.76%+26.99%+93.51%
Globus Medical, Inc. stock logo
GMED
Globus Medical
-1.05%-0.83%+0.21%-5.19%+50.51%
Teleflex Incorporated stock logo
TFX
Teleflex
-2.06%+2.00%+2.10%+4.01%+19.37%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
2.67
Moderate Buy$93.752.74% Upside
Glaukos Corporation stock logo
GKOS
Glaukos
2.73
Moderate Buy$177.333.95% Upside
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.76
Moderate Buy$102.0826.58% Upside
Teleflex Incorporated stock logo
TFX
Teleflex
2.42
Hold$148.908.54% Upside

Current Analyst Ratings Breakdown

Latest ESTA, GMED, GKOS, and TFX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/3/2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Boost Price TargetBuy$95.00 ➝ $117.00
7/31/2026
Teleflex Incorporated stock logo
TFX
Teleflex
Boost Price TargetBuy$147.00 ➝ $159.00
7/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$168.00 ➝ $195.00
7/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$175.00 ➝ $190.00
7/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$175.00 ➝ $188.00
7/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Reiterated RatingOverweight$165.00 ➝ $195.00
7/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetOverweight$138.00 ➝ $178.00
7/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$150.00 ➝ $201.00
7/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$180.00 ➝ $215.00
7/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$164.00 ➝ $193.00
7/28/2026
Teleflex Incorporated stock logo
TFX
Teleflex
Initiated CoverageNeutral$145.00
(Data available from 8/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$229.58M11.70N/AN/A$0.81 per share112.65
Glaukos Corporation stock logo
GKOS
Glaukos
$507.44M19.83N/AN/A$11.57 per share14.75
Globus Medical, Inc. stock logo
GMED
Globus Medical
$2.94B3.72$6.22 per share12.97$33.86 per share2.38
Teleflex Incorporated stock logo
TFX
Teleflex
$1.99B3.05$10.96 per share12.52$70.71 per share1.94
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$51.06M-$1.49N/A651.79N/A-19.05%-218.77%-12.31%8/6/2026 (Estimated)
Glaukos Corporation stock logo
GKOS
Glaukos
-$187.69M-$3.25N/A348.16N/A-30.68%-6.37%-4.78%N/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
$537.87M$4.3018.7516.001.6818.92%13.46%11.65%8/6/2026 (Estimated)
Teleflex Incorporated stock logo
TFX
Teleflex
-$905.64M-$22.80N/A13.001.04-35.88%13.29%6.55%8/6/2026 (Estimated)

Latest ESTA, GMED, GKOS, and TFX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.3368N/AN/AN/A$65.79 millionN/A
8/6/2026Q2 2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
$1.10N/AN/AN/A$782.88 millionN/A
8/6/2026Q2 2026
Teleflex Incorporated stock logo
TFX
Teleflex
$1.28N/AN/AN/A$559.59 millionN/A
7/29/2026Q2 2026
Glaukos Corporation stock logo
GKOS
Glaukos
-$0.2105-$0.14+$0.0705-$0.31$150.93 million$185.61 million
5/7/2026Q1 2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.3550-$0.45-$0.0951-$0.45$57.40 million$59.88 million
5/7/2026Q1 2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.92$1.12+$0.20$0.90$740.35 million$759.85 million
5/7/2026Q1 2026
Teleflex Incorporated stock logo
TFX
Teleflex
$1.21$1.39+$0.18-$0.18$536.91 million$548.30 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
N/AN/AN/AN/AN/A
Glaukos Corporation stock logo
GKOS
Glaukos
N/AN/AN/AN/AN/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
Teleflex Incorporated stock logo
TFX
Teleflex
$1.360.99%N/AN/A N/A

Latest ESTA, GMED, GKOS, and TFX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/15/2026
Teleflex Incorporated stock logo
TFX
Teleflex
quarterly$0.341.03%5/22/20265/25/20266/30/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
16.82
2.96
1.91
Glaukos Corporation stock logo
GKOS
Glaukos
0.10
5.04
4.46
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/A
4.56
2.95
Teleflex Incorporated stock logo
TFX
Teleflex
0.82
2.55
2.03

Institutional Ownership

CompanyInstitutional Ownership
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
72.91%
Glaukos Corporation stock logo
GKOS
Glaukos
99.04%
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
Teleflex Incorporated stock logo
TFX
Teleflex
95.62%

Insider Ownership

CompanyInsider Ownership
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
9.99%
Glaukos Corporation stock logo
GKOS
Glaukos
5.90%
Globus Medical, Inc. stock logo
GMED
Globus Medical
18.38%
Teleflex Incorporated stock logo
TFX
Teleflex
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
1,00429.43 million26.49 millionOptionable
Glaukos Corporation stock logo
GKOS
Glaukos
1,09458.98 million55.50 millionOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
6,000135.74 million110.80 millionOptionable
Teleflex Incorporated stock logo
TFX
Teleflex
15,50044.27 million43.96 millionOptionable

Recent News About These Companies

Teleflex completes $1.5B sale of OEM business, now called Ingenyx
Teleflex Completes OEM Business Sale to Montagu, Kohlberg
Why Is Teleflex (NYSE:TFX) in Focus After FDA Approval?
Teleflex (NYSE:TFX) Reaches New 52-Week High - Here's Why
Teleflex (NYSE:TFX) Raised to "Hold" at UBS Group

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Establishment Labs stock logo

Establishment Labs NASDAQ:ESTA

$91.25 -3.36 (-3.55%)
Closing price 08/5/2026 04:00 PM Eastern
Extended Trading
$92.28 +1.03 (+1.13%)
As of 04:34 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Glaukos stock logo

Glaukos NYSE:GKOS

$170.60 +0.07 (+0.04%)
Closing price 08/5/2026 03:59 PM Eastern
Extended Trading
$170.94 +0.34 (+0.20%)
As of 04:25 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Globus Medical stock logo

Globus Medical NYSE:GMED

$80.64 -0.87 (-1.07%)
Closing price 08/5/2026 03:59 PM Eastern
Extended Trading
$80.62 -0.02 (-0.02%)
As of 08/5/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Teleflex stock logo

Teleflex NYSE:TFX

$137.18 -2.94 (-2.10%)
Closing price 08/5/2026 03:59 PM Eastern
Extended Trading
$136.90 -0.28 (-0.21%)
As of 08/5/2026 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.